Search results
Advancing clinical research: ETPharma’s CREC 2024 spotlights innovations and collaborations - ET...
The Economic Times· 11 hours agoClinical Research: Discussions revolved around challenges, upholding ethical standards as...
BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
Pharmaceutical Technology· 3 days agoAugtyro, an orally administered tyrosine kinase inhibitor (TKI) designed to inhibit specific kinases...
Heart diseases in dogs: Mannuthy Veterinary College to organise free medical camp
Mathrubhumi· 6 days agoThrissur: The College of Veterinary and Animal Sciences, Mannuthy, will be hosting a free medical...
Chronic auto-immune disease often diagnosed late as symptoms it presents are non-specific: Experts
The Telegraph· 4 days agoA chronic auto-immune disease is often diagnosed late because the symptoms it presents are non-specific, experts said at a seminar on Sunday. The seminar was an attempt to ...
Water troughs kept ready at veterinary institutions for livestock brought for treatment
The Hindu· 4 days agoThe move comes in the wake of heatwave prevailing for the last one month and as per the direction of...
Uphill Battle: Navigating the Complexities of Diabetes Management
The Economic Times· 10 hours agoManaging type 2 diabetes involves crucial lifestyle changes for blood sugar control, mental health...
Cases of skin diseases spike as temperature soars in Mumbai
Mid Day· 4 days agoThere is a 40 per cent rise in skin diseases from April due to soaring temperatures. People from all...
Health insurance claim rejection: Widow fights, wins Rs 28 lakh damage; pre-existing disease can't...
The Economic Times· 2 days agoRead here to find out more about the case and what it means for health insurance policyholders....
Aberdeen University study discovers how lifestyle change can impact body fat
Aberdeen Live· 14 hours agoIn the study, researchers investigated how different types of fat are used by the body, depending on...
J&J to buy Proteologix and its dual-targeting antibody drugs for $850M
BioPharma Dive· 10 hours agoThe deal is part of a plan by J&J to build a portfolio of “differentiated” bispecific antibodies, an...